View in EDS

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era.

Saved in:
Bibliographic Details
Title: A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era.
Authors: Robinson, Hannah R.1,2, Junpeng Qi3, Cook, Erika M.1, Nichols, Cydney1, Dadashian, Eman L.1, Underbayev, Chingiz1, Herman, Sarah E. M.1, Saba, Nakhle S.4, Keyvanfar, Keyvan1, Sun, Clare1, Ahn, Inhye E.1, Baskar, Sivasubramanian1, Christoph, Rader3, Wiestner, Adrian1
Source: Blood. 8/2/2018, Vol. 132 Issue 5, p521-532. 12p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first